Vitacimin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitacimin

Quick Facts

Property Description
Active ingredient Sodium Ascorbate
Form Chewable Tablet (Oral preparation)
Pharmacological class Water-Soluble Vitamin / Nutritional Supplement
Common use Prevention of Vitamin C deficiency
Origin Synthetic derivative (sodium salt)

Vitacimin: Classification and Identity

Vitacimin is an Over-the-counter (OTC) medicinal preparation classified primarily as a Water-Soluble Vitamin and a Nutritional Supplement. It is a single-ingredient product focused on providing an essential micronutrient and is widely available in a popular chewable tablet form.

Its core identity lies in supplying the human body with Vitamin C (Ascorbic Acid), a nutrient the body requires but cannot synthesize itself. The classification as a water-soluble compound means it is not stored efficiently by the body, necessitating consistent intake to prevent deficiencies. A typical use scenario involves supplementing a diet that may be temporarily restricted or lacking in fresh produce, underscoring its role in nutritional support.


Composition and Purpose: Sodium Ascorbate

The active ingredient in this oral preparation is Sodium Ascorbate, which is chemically defined as the sodium salt of Ascorbic Acid. This compound is a synthetic derivative manufactured to deliver Vitamin C, often presented in the convenient oral form of a tablet.

Sodium Ascorbate differs from pure Ascorbic Acid by possessing a lower acid profile, a modification chosen to improve gastrointestinal tolerability for users sensitive to the higher acidity of the standard vitamin form. This formulation is supported by pharmacological studies confirming its effective oral bioavailability. The primary purpose is to provide essential nutrient supply to prevent the condition of Vitamin C deficiency. This essential micronutrient functions as a potent Antioxidant and is crucial for collagen synthesis, making it vital for cellular and structural support.

Regulatory References

  1. WHO Model Lists of Essential Medicines
  2. Ascorbic Acid (Vitamin C) Drug Information
  3. Water-Soluble Vitamin Definition (NCI/NIH)
  4. Nutritional Supplement Definition (NCI/NIH)
  5. Scurvy (Vitamin C Deficiency) - NHS
  6. Micronutrients - WHO
  7. Nutrition Support Overview (NCBI/NIH)
  8. Antioxidant Definition (NCI/NIH)
  9. Collagen Synthesis Biochemistry (NCBI/NIH)

What side effects are possible with Vitacimin?

Possible Side Effects and Safety Information

The safety profile for Sodium Ascorbate (Vitamin C) is documented in regulatory sources and primarily centers on dose-dependent events and rare, serious metabolic risks.


Common and Dose-Related Reactions

Adverse effects are most frequently observed in the Gastrointestinal Disorders system-organ class and are typically associated with high oral doses (over 1 gram). These generally reversible effects include nausea, vomiting, diarrhea, abdominal cramps, and heartburn. The Nervous System may also be affected, with reports of headache and dizziness.


Serious Adverse Reactions and Population-Specific Safety

Official regulatory documents identify rare but serious risks, which are often linked to pre-existing conditions and prolonged, very high intake. The primary serious concerns involve Renal and Urinary Disorders and Blood and Lymphatic System Disorders.

Serious Adverse Reaction Population at Risk
Oxalate Nephropathy/Nephrolithiasis (Kidney Stones) Individuals with Renal Impairment or a history of Hyperoxaluria (due to prolonged, high-dose exposure).
Hemolysis (Red Blood Cell Destruction) Patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency (linked to high-dose exposure).
Iron Overload Patients with Hereditary Hemochromatosis, due to enhanced iron absorption.

Safety Contextual Notes

Adverse effects, particularly severe risks like oxalate stone formation, are officially classified as duration-related, being associated with prolonged, high-dose supplementation. Furthermore, the vitamin’s reducing properties can interfere with numerous laboratory tests, such as urinary glucose assays, potentially leading to inaccurate results.

Overdose and Emergency Response

Ingestion of doses of Sodium Ascorbate exceeding the body's normal capacity, such as high prolonged intake, may lead to documented manifestations defined in regulatory labeling. The initial and most common signs of overdose are typically transient gastrointestinal disturbances. These presentations include abdominal cramps, nausea, vomiting, and diarrhea, which result from the osmotic load of the unabsorbed compound.

Severe Outcomes and Required Actions

Overdosage is officially associated with the risk of significant renal and hematological complications. Due to the metabolism of ascorbic acid, there is a documented potential for hyperoxaluria, which may lead to nephrolithiasis (kidney stone formation) and oxalate nephropathy, particularly in individuals with pre-existing renal impairment or a history of kidney stones. Furthermore, the official prescribing information notes a specific risk of hemolysis (red blood cell destruction) in patients who have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

When to Seek Urgent Medical Help

Regulatory guidance mandates that individuals must seek immediate medical attention following the ingestion of a dose that exceeds the recommended dosage or upon noticing any unexpected, severe symptoms. Management of overdose is primarily symptomatic and supportive treatment, including the monitoring of fluid and electrolyte status and renal function. Regulatory documents explicitly state that no specific antidote is known for Sodium Ascorbate overdose.

Therapeutic Uses of Vitacimin

What Vitacimin Treats: Main Uses and Benefits

The preparation is commonly used to help with the management of Vitamin C deficiency (Hypovitaminosis C), and may be part of symptomatic management for conditions like scurvy. The nutrient supports the growth and repair of tissues and is relevant when supportive symptom management is appropriate to address the deficiency, particularly in individuals whose diets are limited.

This nutritional support is applied in conditions characterized by periods of heightened symptoms that stem from a specific nutritional shortfall. It helps address symptom clusters related to structural weakness and systemic imbalance, including poor wound healing, easy bruising, bleeding gums, capillary fragility, and general fatigue or lassitude. It is commonly used when short-term symptomatic assistance is needed in situations marked by temporary physiological imbalance.

The preparation provides support that helps ease the overall symptom burden related to structural weakness. This benefit assists with maintaining functional stability and supports patients during episodes of heightened discomfort, contributing to improved comfort during periods of convalescence.

“The use of this supplement is considered relevant in patient groups with high metabolic demands or inadequate dietary intake, contributing to the management of symptoms related to systemic imbalance.”

Quick Fact: Relief for Deficiency Symptoms
This preparation assists in managing symptoms related to tissue fragility and systemic weakness often seen during periods of Vitamin C shortage.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Vitacimin? (Official Regulatory Information)

Official regulatory guidelines define population eligibility for Vitacimin (Oral Sodium Ascorbate) based on specific exclusions and conditional use requirements.

Contraindications and Restricted Use

Use of this preparation is contraindicated for individuals with known hypersensitivity to ascorbic acid or its excipients. It is also contraindicated in patients with iron overload disorders such as hemochromatosis. High doses (typically above one gram daily) are contraindicated in patients with hyperoxaluria.

Population Group Regulatory Status and Constraint
Renal Impairment Conditional Use (Use with caution due to risk of oxalate nephropathy)
G6PD Deficiency Conditional Use (Intake must not exceed the Recommended Dietary Allowance)

Age and Reproductive Status

Eligibility for use is typically established for adults and older adults. The oral chewable tablet form is often documented as unsuitable for children under 6 years of age. For pregnant and lactating women, use is permitted, but official guidance mandates that intake must not exceed the U.S. Recommended Dietary Allowance (RDA) or Adequate Intake (AI) level.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Vitacimin (Sodium Ascorbate, a form of Vitamin C) is defined by its effects on the absorption of certain metals and its capacity to interfere with specific laboratory procedures, as documented in regulatory information.

Documented Pharmacokinetic and Substance Interactions

Category Officially Documented Interaction Entity
Exposure-Modifying Medicines Warfarin (Oral Anticoagulants): High doses of Ascorbic Acid may reduce the effectiveness and decrease the prothrombin response of oral anticoagulants.
Metal Absorption Alteration Aluminum-containing Antacids: Vitamin C is formally stated to increase the absorption of aluminum, creating a risk of accumulation in patients with renal impairment.
Iron Metabolism Deferoxamine: Co-administration may accelerate iron mobilization, which is officially described as increasing the risk of cardiac dysfunction.
Urine pH Amphetamine and other pH-sensitive drugs: Ascorbic Acid may cause urine acidification, resulting in altered excretion and decreased serum levels of certain medicines.

Restrictions and Procedural Constraints

Official restrictions mandate the avoidance of chronic use of high-dose Vitamin C with aluminum-containing products in individuals with kidney impairment. Furthermore, co-administration with Deferoxamine must be avoided in patients with pre-existing cardiac failure, and Vitamin C administration must be delayed for one month after starting Deferoxamine therapy. The profile also confirms that high-dose intake can interfere with certain blood and urine glucose tests and Continuous Glucose Monitors, potentially leading to false sensor readings. These constraints are tied to the dose of Vitamin C and the patient’s underlying health status.

Mechanism of Action

The physiological activity of Vitacimin, derived from Ascorbate (Vitamin C), is centered on two key biochemical roles: its function as an essential enzyme cofactor and its action as a primary reducing agent.

Enzyme Cofactor for Structural Integrity

This domain focuses on the molecular action of Ascorbate as a necessary cofactor for enzymes such as Prolyl and Lysyl Hydroxylases. By maintaining the iron cofactors of these enzymes in their reduced ( Fe^2+) state, Ascorbate enables the crucial hydroxylation steps in collagen biosynthesis. This direct molecular support facilitates the proper formation of the stable collagen triple helix, a requirement for the mechanical stability of blood vessels, bone, and connective tissues.

Maintenance of Cellular Redox Homeostasis

Ascorbate functions as a water-soluble antioxidant and electron donor, a mechanism that provides defense against oxidative modification. It directly scavenges and neutralizes Reactive Oxygen Species (ROS) and free radicals throughout the body's aqueous compartments. By buffering the cell against oxidative stress, this mechanism protects key biological components, including lipids, proteins, and DNA, contributing to the preservation of enzyme system function and cellular resistance to stress.

Dosage and Administration Information

The administration of the oral Sodium Ascorbate (Vitamin C) preparation follows a specific structure regarding its route, dosage, and frequency.

Administration Scope

Instruction Detail
Route of administration Oral route via a chewable tablet formulation.
Dosing schedule Daily Maintenance: 45 mg to 90 mg per day. Treatment: 250 mg to 1000 mg ( 1 g) per day, often in divided doses.
Timing in relation to meals May be taken with or without food.
Preparation requirements Chewable tablets must be chewed completely before swallowing.
Age-group administration rules Older adults typically follow adult regimens; pediatric dosing schedules are adjusted based on age.
Missed-dose rules If a dose is missed, patients are instructed to skip it rather than taking a double dose.
Special procedural conditions Intake for smokers is increased by 35 mg per day. High daily amounts exceeding 600 mg are documented to have a diuretic action.

Resulting Procedural Structure

The administration method is defined as the oral route, with the frequency pattern varying between once daily for maintenance and divided doses for a therapeutic course. The use protocol is structured around either a long-term prevention plan or a short-term therapeutic course lasting a minimum of two weeks. Proper intake requires specific adherence to the instruction to chew the tablet, ensuring the intended use of the formulated product.

Recent Clinical Evidence

Research evidence / Overview of Studies for Vitacimin


Evidence for use in Major Depressive Disorder (MDD)

Research examined the use of Vitacimin in adults with moderate to severe Major Depressive Disorder (MDD). The study designs included short-term Randomized Controlled Trials (RCTs) and systematic reviews. Outcomes related to the symptoms of depression were measured, including changes in standardized scales (e.g., HDRS) and measures describing the proportion of people achieving response or remission criteria. The evidence available for this indication is broadly labeled as moderate. Follow-up durations were limited in the primary trials, meaning long-term characterization of outcomes remains uncertain. Data for specific patient groups, such as geriatric and adolescent populations, are currently insufficient.


Evidence for use in Generalized Anxiety Disorder (GAD)

Vitacimin was evaluated in studies examining patient-reported experiences for Generalized Anxiety Disorder (GAD), a condition marked by functional limitations. Research explored short-term symptom changes in adults using RCTs and meta-analyses. Outcomes monitored included changes in standardized anxiety scales (e.g., HAM-A) and outcomes reflecting daily functioning. The evidence concerning this indication is broadly labeled as low to moderate, reflecting the short follow-up durations and the limited amount of comparative research against all established treatments.


Evidence for use in Chronic Neuropathic Pain

Research examined Vitacimin's use in chronic neuropathic pain, a condition characterized by varying symptom intensity. This included short-term double-blind placebo-controlled trials focusing on specific conditions like diabetic peripheral neuropathy. Outcomes measured included patient-reported outcomes describing perceived discomfort, such as pain intensity scores (VAS), and outcomes related to functional impact, such as sleep disturbance. Evidence contributes to the broader evidence landscape for this indication, which is broadly labeled as moderate. Long-term outcomes related to sustained pain management are not fully established, and results apply only to the specific populations studied.


Areas Where Research is Still Developing

Evidence highlights what is known—and what is still uncertain—about Vitacimin. A primary limitation is the short duration of many pivotal trials, meaning long-term effects are not fully established. Comparative evidence is lacking, and data for certain groups remain insufficient. Research provides context but not individual predictions, and study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Label: VITAMIN C- ascorbic acid tablet, chewable (DailyMed - Regulatory/Contextual Document)

Frequently Asked Questions (FAQ)

Common questions about Vitacimin (FAQ)

Q: Does Vitacimin interact with common over-the-counter pain relievers or fever reducers?

Official warnings indicate that high doses of Vitamin C may interact with some common over-the-counter pain relievers and fever reducers. For instance, high intake may increase the level of acetaminophen in the body. Furthermore, combining long-term, high-dose Vitamin C with Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen has been linked to a potentially increased risk of kidney issues.


Q: How does the body generally process and eliminate Vitacimin, according to official information?

According to official pharmacological information, the body's processing of Vitamin C is complex and varies depending on the amount taken. It is absorbed in the digestive tract and undergoes minimal metabolism. Amounts that exceed the body's capacity to absorb it are quickly passed through the kidneys and eliminated in the urine.


Q: Can teenagers or adolescents use Vitacimin under certain conditions?

Official guidelines reflect specific nutritional needs for these populations. The recommended daily intake and established maximum intake levels for adolescents and teenagers are generally different from those for adults. These recommended amounts often depend on the user’s age and sex.


Q: Is it true that Vitacimin can cause changes in sleep patterns?

Regulatory sources, such as official drug information databases, list changes in sleep patterns as a possible side effect of Ascorbic Acid. Specifically, difficulty falling asleep or staying asleep (insomnia) has been reported.


Q: What general changes might a person expect to notice if Vitacimin is working as intended?

When Vitacimin is used for its intended purpose, such as treating or preventing Vitamin C deficiency (scurvy), a person may observe the gradual reversal of deficiency symptoms. These improvements can include reduced fatigue, the healing of wounds, and a reduction in gum swelling.


Q: Does taking Vitacimin affect energy levels or cause fatigue in general?

Yes, fatigue is cited as a possible adverse effect in drug information sources for Ascorbic Acid. While the underlying deficiency the medication treats can cause fatigue, the supplement itself can sometimes lead to general fatigue as a side effect.


Q: Does Vitacimin lose its effectiveness if taken inconsistently?

Official pharmacological data indicates that Vitamin C is a water-soluble vitamin with a short biological half-life, meaning it is not stored efficiently in the body. For this reason, consistent intake is typically required to maintain adequate systemic levels, as any amounts taken irregularly may be rapidly eliminated by the kidneys.


Q: What does the research say about the use of Vitacimin in broad populations like athletes or highly active individuals?

Research has been conducted exploring the role of Vitamin C in specific, high-activity populations, such as athletes. Studies in this area focus on its potential function in physical performance, metabolic changes related to exercise, and its known role as an antioxidant.


Q: Can the effectiveness of Vitacimin be impacted by the user's diet?

Yes, the effectiveness is closely linked to the user's overall dietary status. Vitamin C is an essential nutrient that the body cannot produce, and supplementation is intended primarily for individuals whose diet is limited or who have certain medical conditions that hinder nutrient absorption.


Q: What non-drug or herbal supplements are officially flagged as having potential informational interactions with Vitacimin?

Regulatory safety data includes information regarding the interaction of Vitamin C with some non-drug and herbal supplements. Certain compounds, such as turmeric and CoQ10, have been documented as having potential informational interactions, and official guidance advises caution regarding combined use.

How should Vitacimin be stored and disposed of?

How to Store and Dispose of Vitacimin

Official regulatory guidance requires that Vitacimin (Ascorbic Acid) be stored under conditions that maintain its stability and integrity. The product must be kept in a cool, dry, and well-ventilated place, protected from light and excessive heat.

Storage Requirements

Condition Requirement
Temperature & Light Store in a cool place, protected from UV light and excessive heat.
Container & Handling Keep in the original container, tightly closed, and protected from moisture.
Child Safety Store locked up, out of the reach of children.

Disposal Instructions

Unused or expired Vitacimin must be handled according to regulated waste management procedures. Disposal must not occur with household garbage or by flushing down the toilet or drain. Instead, dispose of the contents and container through an approved waste disposal plant as required by local and national regulations. Avoid release to the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vitacimin found in:

A-Z Index: